Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea - Global

Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea

The purpose of this study, is to assess the effect of lanreotide Autogel 120mg on stool frequency in subjects with refractory diarrhea at day 28 (mean of last 7 days) compared to baseline.

En rapport Clinical Trials